featured
MyProstateScore to Rule Out Clinically-Significant Cancer in Men With PI-RADS 3 Multiparametric MRI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Urinary MyProstateScore (MPS) to rule out clinically-significant cancer in men with equivocal (PI-RADS 3) multiparametric MRI: addressing an unmet clinical need
Urology 2021 Dec 11;[EPub Ahead of Print], JJ Tosoian, U Singhal, MS Davenport, JT Wei, JS Montgomery, AK George, SS Salami, SG Mukundi, J Siddiqui, LP Kunju, BP Tooke, CY Ryder, SP Dugan, Z Chopra, R Botbyl, Y Feng, MS Sessine, NW Eyrich, AE Ross, BJ Trock, SA Tomlins, GS Palapattu, AM Chinnaiyan, YS Niknafs, TM MorganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.